SandrinePirardMDPhD, MPH

PubMed

• 30 citations
  Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationshi...
  Sofia Bouhlal, Kayla N. Ellefsen, Mikela B. Sheskier, Erick Singley, Sandrine Pirard, David A. Gorelick, Marilyn A. Huestis, Lorenzo Leggio> ;Drug and Alcohol Dependence. 2017 Nov 1
• 13 citations
  Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration.
  Kayla N. Ellefsen, Marta Concheiro, Sandrine Pirard, David A. Gorelick, Marilyn A. Huestis> ;Drug and Alcohol Dependence. 2016 Jun 1
• 15 citations
  Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.
  Kayla N. Ellefsen, Marta Concheiro, Sandrine Pirard, David A. Gorelick, Marilyn A. Huestis> ;Forensic Science International. 2016 Mar 1
• 8 citations
  Cocaine and benzoylecgonine oral fluid on‐site screening and confirmation
  Kayla N. Ellefsen, Marta Concheiro, Sandrine Pirard, David A. Gorelick, Marilyn A. Huestis> ;Drug Testing and Analysis. 2016 Mar 1
• 21 citations
  Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration.
  Kayla N. Ellefsen, Jose Luiz Costa, Marta Concheiro, Sebastien Anizan, Allan J. Barnes, Sandrine Pirard, David A. Gorelick, Marilyn A. Huestis> ;Bioanalysis. 2015 Sep 1
• Markers of Impaired Decision Making in Nursing Home Residents: Assessment by Nursing Home Staff in a Population-Based Study.
  Kevin M. Fain, Paul B. Rosenberg, Sandrine Pirard, Olivera Bogunovic, Adam P. Spira> ;Journal of the American Medical Directors Association. 2015 Jul 1
• 385 citations
  Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
  Marisol S. Castaneto, David A. Gorelick, Nathalie A. Desrosiers, Rebecca L. Hartman, Sandrine Pirard, Marilyn A. Huestis> ;Drug and Alcohol Dependence. 2014 Nov 1
• 18 citations
  Quantification of cocaine and metabolites in exhaled breath by liquid chromatography-high-resolution mass spectrometry following controlled administration of intraveno...
  Kayla N. Ellefsen, Marta Concheiro, Olof Beck, David A. Gorelick, Sandrine Pirard, Marilyn A. Huestis> ;Analytical and Bioanalytical Chemistry. 2014 Aug 17
• 16 citations
  No-Show for Treatment in Substance Abuse Patients with Comorbid Symptomatology: Validity Results from a Controlled Trial of the ASAM Patient Placement Criteria.
  Gustavo A. Angarita, Sharon Reif, Sandrine Pirard, Sang Lee, Estee Sharon, David R. Gastfriend> ;Journal of Addiction Medicine. 2007 Jun 1
• 60 citations
  Prevalence of physical and sexual abuse among substance abuse patients and impact on treatment outcomes
  Sandrine Pirard, Estee Sharon, Shimi K. Kang, Gustavo A. Angarita, David R. Gastfriend> ;Drug and Alcohol Dependence. 2005 Apr 4
• 5-HT1A dysfunction in borderline personality disorder.
  Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., Pirard, S., Ansseau, M.> ;Psychol Med. 2002 Jul
• [Decision analysis in radiology].
  Janne d'Othée, B., Black, W. C., Pirard, S., Zhuang, Z., Bettmann, M. A.> ;J Radiol. 2001 Dec
• [Studies of cost-effectiveness and cost-usefulness in radiology].
  Janne d'Othée, B., Bettmann, M. A., Pirard, S., Zhuang, Z., Black, W. C.> ;J Radiol. 2001 Dec
• Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality.
  Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Pinto, E., Reggers, J., Fuchs, S., Pirard, S., Ansseau, M.> ;Psychoneuroendocrinology. 2001 Oct
• Reduced dopaminergic activity in depressed suicides.
  Pitchot, W., Reggers, J., Pinto, E., Hansenne, M., Fuchs, S., Pirard, S., Ansseau, M.> ;Psychoneuroendocrinology. 2001 Apr
• A 295-kDA intermediate filament-associated protein in radial glia and developing muscle cells in vivo and in vitro.
  Chanas-Sacré, G., Thiry, M., Pirard, S., Rogister, B., Moonen, G., Mbebi, C., Verdière-Sahuqué, M., Leprince, P.> ;Dev Dyn. 2000 Dec
• Identification of PSF, the polypyrimidine tract-binding protein-associated splicing factor, as a developmentally regulated neuronal protein.
  Chanas-Sacré, G., Mazy-Servais, C., Wattiez, R., Pirard, S., Rogister, B., Patton, J. G., Belachew, S., Malgrange, B., Moonen, G., Leprince, P.> ;J Neurosci Res. 1999 Jul 1
• Join now to see all